Piramal enterprises share

Piramal also has a strong presence in the anaesthesia market. The company is fourth globally when it comes to inhalation anaesthesia. This business is categorised by lower competition and higher barriers to entry. While it did see a hit during COVID-19, it is on the path to recovery as hospitalisations and surgeries have picked up. The business grew 20 percent in FY22 and 10 percent in the first quarter of the 2022-23 fiscal year. The CDMO business has been impacted by execution-related challenges. While the company did not share the overall guidance for FY23 due to volatility, the Street will watch for the company’s ability to meet long-term guidance, especially on the margins, which are currently below the industry average at 11 percent. The pharma entity's shares are expected to be listed by the third quarter of the 2022-23 fiscal year. CLSA has a mid-October timeline. The likes of CLSA are valuing the company at Rs 1,030 crore, including Carlyle’s stake of 20 percent. This should translate to Rs 206 per share on the listing of Piramal Pharma.

Piramal Enterprises share price trades ex-demerger ahead of record date, what should investors know The company’s board earlier in October 2021 had approved the demerger of Piramal Ent and Piramal Pharma as two separated entities. The former to handle financial services business and the latter to have a pharmaceutical business. • • • • • At the market close, shares of PEL jumped over 1 per cent higher to Rs 1,062.75 per share on the BSE. The counter opened at the ex-demerger price of Rs 1,050 apiece on the BSE. Piramal Enterprises' demerger record date is September 1, 2022 and the company will issue 4 equity shares of Rs 10 each of Piramal Pharma for every 1 equity share of Rs 2 each to shareholders of Piramal Enterprises Limited. Piramal Enterprises will have a financial services business, including retail and wholesale lending, while Piramal Pharma, which will be relisted on exchanges after the demerger, would have a pharma, and CDMO business, according to Zee Business research analyst Nupur Jainkunia. The pharma entity will be listed in the next 3-4 quarters of the ongoing fiscal year, the analyst said. On the book value of 1.3/1.4 times, Piramal Enterprises' share price comes to Rs 1415 per share with respect to FY24e and Piramal Pharma's share price comes to Rs 915 per share on 17 times EV/EBITDA on an average after factoring 20 per cent holding discount, Zee Business analyst The total share price value comes to Rs 2330 per share, which shows around an 18-20 per cent ...

Meeting Date Announced on Purpose Details May 05, 2023 May 02, 2023 Board Meeting Audited Results & Final Dividend Feb 08, 2023 Feb 01, 2023 Board Meeting Quarterly Results Nov 09, 2022 Nov 02, 2022 Board Meeting Quarterly Results Jul 29, 2022 Jul 22, 2022 Board Meeting Quarterly Results Jul 29, 2022 May 26, 2022 AGM - • All Types Ex-Date Record Date Announced on Details Rights Dec 30, 2019 Dec 31, 2019 Oct 25, 2019 Rights ratio: 11 share for every 83 held at a price of Rs 1300.0 Rights Jan 31, 2018 Feb 01, 2018 Oct 12, 2017 Rights ratio: 1 share for every 23 held at a price of Rs 2380.0 Rights Jun 24, 2005 - Mar 12, 2005 Rights ratio: 1 share for every 10 held at a price of Rs 175.0 Splits Dec 27, 2004 Jan 03, 2005 Oct 21, 2004 Split: Old FV10.0| New FV:2.0 Bonus May 21, 1993 Jun 11, 1993 Sep 30, 1993 Bonus Ratio: 1 share(s) for every 2 shares held About Piramal Ent. Piramal Enterprises Ltd., incorporated in the year 1947, is a Large Cap company (having a market cap of Rs 18,671.85 Crore) operating in Diversified sector. Piramal Enterprises Ltd. key Products/Revenue Segments include Pharmaceuticals, Interest, Income From Financial Services, Sale of services, Dividend, Other Operating Revenue for the year ending 31-Mar-2022. For the quarter ended 31-03-2023, the company has reported a Consolidated Total Income of Rs 2,143.02 Crore, down 34.81 % from last quarter Total Income of Rs 3,287.13 Crore and down 51.31 % from last year same quarter Total Income of Rs 4,401.03 Crore...

Piramal Enterprises Ltd.: Share Price, Stock Analysis, Annual Report | Value Research Piramal Enterprises Ltd.: Share Price, Stock Analysis, Annual Report | Value Research https://www.valueresearchonline.com/stocks/43790/piramal-enterprises-ltd/ Get Piramal Enterprises Ltd.'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house. Business Piramal Enterprises Limited operates as a non-banking financial company in India. The company provides housing finance and other financing solutions, such as private equity, structured debt, senior secured debt, construction finance, and flexi lease rental discounting to real estate sector; and funding solutions to infrastructure, renewable energy, roads, industrials, auto components, and other sectors. It also operates distressed asset investing platform that invests in equity and/or debt in assets; provides life insurance services, as well as engages in fund management, property leasing, and manpower services businesses. The company was formerly known as Piramal Healthcare Limited and changed its name to Piramal Enterprises Limited in July 2012. Piramal Enterprises Limited was incorporated in 1947 and is headquartered in Mumbai, India. AMCs: • 360 ONE • Aditya Birla Sun Life • Axis • Bandhan • Bank of India • Baroda BNP Paribas • Canara Robeco • DSP • Edelweiss • Franklin Templeton • Groww • HDFC • HSBC • ICICI Prudential • IDBI • Invesco • ITI • JM Financial • Kotak Mahin...

Piramal Enterprises Ltd. is a Public Limited Listed company incorporated on 26/04/1947 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24110MH1947PLC005719 and registration number is 005719. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 2225.68 Cr. and Equity Capital is Rs. 47.73 Cr. for the Year ended 31/03/2022.

Si vous cliquez sur Accepter tout, • afficher des publicités et des contenus personnalisés en fonction de vos profils de centres d’intérêt ; • mesurer l’efficacité des publicités et contenus personnalisés ; et • développer et améliorer nos produits et services. Si vous ne souhaitez pas que nos partenaires et nous–mêmes utilisions des cookies et vos données personnelles pour ces motifs supplémentaires, cliquez sur Refuser tout. Si vous souhaitez personnaliser vos choix, cliquez sur Gérer les paramètres de confidentialité. Vous pouvez modifier vos choix à tout moment en cliquant sur les liens « Paramètres de confidentialité et des cookies » ou « Tableau de bord sur la confidentialité » présents sur nos sites et dans nos applications. Découvrez comment nous utilisons vos données personnelles dans notre

Piramal Enterprises Ltd.: Share Price, Stock Analysis, Annual Report | Value Research Piramal Enterprises Ltd.: Share Price, Stock Analysis, Annual Report | Value Research https://www.valueresearchonline.com/stocks/43790/piramal-enterprises-ltd/ Get Piramal Enterprises Ltd.'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house. Business Piramal Enterprises Limited operates as a non-banking financial company in India. The company provides housing finance and other financing solutions, such as private equity, structured debt, senior secured debt, construction finance, and flexi lease rental discounting to real estate sector; and funding solutions to infrastructure, renewable energy, roads, industrials, auto components, and other sectors. It also operates distressed asset investing platform that invests in equity and/or debt in assets; provides life insurance services, as well as engages in fund management, property leasing, and manpower services businesses. The company was formerly known as Piramal Healthcare Limited and changed its name to Piramal Enterprises Limited in July 2012. Piramal Enterprises Limited was incorporated in 1947 and is headquartered in Mumbai, India. AMCs: • 360 ONE • Aditya Birla Sun Life • Axis • Bandhan • Bank of India • Baroda BNP Paribas • Canara Robeco • DSP • Edelweiss • Franklin Templeton • Groww • HDFC • HSBC • ICICI Prudential • IDBI • Invesco • ITI • JM Financial • Kotak Mahin...

• Adani Enterp. 2484.80 ↑ 33.65 (1.37%) • Adani Ports 742.10 ↑ 7.15 (0.97%) • Apollo Hospitals 4924.75 ↓ -1.95 (-0.04%) • Asian Paints 3194.75 ↑ 14.20 (0.45%) • Axis Bank 974.20 ↓ -0.55 (-0.06%) • B P C L 371.65 ↑ 12.20 (3.39%) • Bajaj Auto 4769.65 ↑ 26.25 (0.55%) • Bajaj Finance 7097.70 ↑ 60.55 (0.86%) • Bajaj Finserv 1466.00 ↓ -0.50 (-0.03%) • Bharti Airtel 836.35 ↑ 2.85 (0.34%) • Britannia Inds. 4900.25 ↑ 21.50 (0.44%) • Cipla 959.95 ↓ -9.30 (-0.96%) • Coal India 229.00 ↑ 1.35 (0.59%) • Divi's Lab. 3438.45 ↑ 9.70 (0.28%) • Dr Reddy's Labs 4675.65 ↑ 8.85 (0.19%) • Eicher Motors 3590.60 ↑ 9.30 (0.26%) • Grasim Inds 1731.40 ↑ 15.65 (0.91%) • H D F C 2640.80 ↓ -12.10 (-0.46%) • HCL Technologies 1139.65 ↑ 29.90 (2.69%) • HDFC Bank 1600.80 ↓ -9.80 (-0.61%) • HDFC Life Insur. 584.40 ↑ 2.70 (0.46%) • Hero Motocorp 2930.40 ↑ 31.10 (1.07%) • Hind. Unilever 2643.45 ↑ 7.25 (0.28%) • Hindalco Inds. 416.80 ↑ 1.75 (0.42%) • ICICI Bank 935.95 ↓ -2.10 (-0.22%) • IndusInd Bank 1332.45 ↑ 1.40 (0.11%) • Infosys 1291.95 ↑ 26.00 (2.05%) • ITC 436.95 ↓ -1.50 (-0.34%) • JSW Steel 747.30 ↓ -1.20 (-0.16%) • Kotak Mah. Bank 1879.45 ↑ 7.45 (0.40%) • Larsen & Toubro 2339.95 ↓ -23.05 (-0.98%) • M & M 1381.40 ↑ 10.75 (0.78%) • Maruti Suzuki 9550.45 ↓ -77.35 (-0.80%) • Nestle India 22289.35 ↑ 215.90 (0.98%) • NTPC 185.70 ↑ 2.90 (1.59%) • O N G C 155.05 ↑ 0.80 (0.52%) • Power Grid Corpn 241.65 ↓ -3.25 (-1.33%) • Reliance Industr 2484.15 ↑ 2.20 (0.09%) • SBI Life Insuran 1238.90 ↑ 6.50 (0.53%) • St Bk o...

Meeting Date Announced on Purpose Details May 05, 2023 May 02, 2023 Board Meeting Audited Results & Final Dividend Feb 08, 2023 Feb 01, 2023 Board Meeting Quarterly Results Nov 09, 2022 Nov 02, 2022 Board Meeting Quarterly Results Jul 29, 2022 Jul 22, 2022 Board Meeting Quarterly Results Jul 29, 2022 May 26, 2022 AGM - • All Types Ex-Date Record Date Announced on Details Rights Dec 30, 2019 Dec 31, 2019 Oct 25, 2019 Rights ratio: 11 share for every 83 held at a price of Rs 1300.0 Rights Jan 31, 2018 Feb 01, 2018 Oct 12, 2017 Rights ratio: 1 share for every 23 held at a price of Rs 2380.0 Rights Jun 24, 2005 - Mar 12, 2005 Rights ratio: 1 share for every 10 held at a price of Rs 175.0 Splits Dec 27, 2004 Jan 03, 2005 Oct 21, 2004 Split: Old FV10.0| New FV:2.0 Bonus May 21, 1993 Jun 11, 1993 Sep 30, 1993 Bonus Ratio: 1 share(s) for every 2 shares held About Piramal Ent. Piramal Enterprises Ltd., incorporated in the year 1947, is a Large Cap company (having a market cap of Rs 18,671.85 Crore) operating in Diversified sector. Piramal Enterprises Ltd. key Products/Revenue Segments include Pharmaceuticals, Interest, Income From Financial Services, Sale of services, Dividend, Other Operating Revenue for the year ending 31-Mar-2022. For the quarter ended 31-03-2023, the company has reported a Consolidated Total Income of Rs 2,143.02 Crore, down 34.81 % from last quarter Total Income of Rs 3,287.13 Crore and down 51.31 % from last year same quarter Total Income of Rs 4,401.03 Crore...

Piramal Enterprises share price trades ex-demerger ahead of record date, what should investors know The company’s board earlier in October 2021 had approved the demerger of Piramal Ent and Piramal Pharma as two separated entities. The former to handle financial services business and the latter to have a pharmaceutical business. • • • • • At the market close, shares of PEL jumped over 1 per cent higher to Rs 1,062.75 per share on the BSE. The counter opened at the ex-demerger price of Rs 1,050 apiece on the BSE. Piramal Enterprises' demerger record date is September 1, 2022 and the company will issue 4 equity shares of Rs 10 each of Piramal Pharma for every 1 equity share of Rs 2 each to shareholders of Piramal Enterprises Limited. Piramal Enterprises will have a financial services business, including retail and wholesale lending, while Piramal Pharma, which will be relisted on exchanges after the demerger, would have a pharma, and CDMO business, according to Zee Business research analyst Nupur Jainkunia. The pharma entity will be listed in the next 3-4 quarters of the ongoing fiscal year, the analyst said. On the book value of 1.3/1.4 times, Piramal Enterprises' share price comes to Rs 1415 per share with respect to FY24e and Piramal Pharma's share price comes to Rs 915 per share on 17 times EV/EBITDA on an average after factoring 20 per cent holding discount, Zee Business analyst The total share price value comes to Rs 2330 per share, which shows around an 18-20 per cent ...